Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas (MarZoLyOss)

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Enrolling

Conditions: Marginal Zone B Cell Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT06806488

MarZoLyOss

Details and patient eligibility

About

This is a purely retrospective and observational monocentric study

Full description

the study aimed at describing the characteristics and outcome of Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018

Enrollment: 160 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.
2. Age ≥ 18 years at enrolment.
3. Written informed consent (if applicable)

Exclusion criteria

• none